Abstract
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare neoplasm responsible for 0.04% to 0.5% of all cases of breast disease. It occurs in patients with a previous history of breast implants that generally progress without complications during the first years of post-operatory and is mainly associated with macro-textured implants. Due to its low incidence, it does not represent the first probable diagnosis in patients with a breast tumor. This article reports the case of a patient with BIA-ALCL initially treated as a Hodgkin's lymphoma. We emphasize the importance of a correct and complete diagnosis by immunohistochemistry before imaging in patients that develop a breast tumor associated with the prosthetic capsule after breast implant surgery and its adequate treatment, including surgery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Science and Technology Research Archive
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
